Research ArticleHuman Studies
Comparison of 1073 MBq and 3700 MBq Iodine-131 in Postoperative Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Cancer
Klaus Johansen, Nicholas J.Y. Woodhouse and Ola Odugbesan
Journal of Nuclear Medicine February 1991, 32 (2) 252-254;
Klaus Johansen
Nicholas J.Y. Woodhouse


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Comparison of 1073 MBq and 3700 MBq Iodine-131 in Postoperative Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Cancer
Klaus Johansen, Nicholas J.Y. Woodhouse, Ola Odugbesan
Journal of Nuclear Medicine Feb 1991, 32 (2) 252-254;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients
- The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
- The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies
- Ablation of the Thyroid Remnant and I-131 Dose in Differentiated Thyroid Cancer: A Meta-Analysis Revisited
- Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report